{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-088578","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.308092+00:00","generated_at":"2026-05-31T14:16:21.525653+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Standard BioTools Q2 revenue $37.2M, net loss $45.7M; FY2024 guidance cut to $170-175M","bullets":["Q2 revenue $37.2M (pro forma combined -23% YoY); net loss $45.7M; adjusted EBITDA loss $31.0M.","FY2024 revenue guidance reduced to $170-$175M from prior expectation; cites weaker SomaScan services and capital spending slowdown.","Accelerated merger synergy target: $80M cost reductions expected operationalized by end of 2024, a year ahead of plan.","Repurchased ~11.3M shares in Q2 for ~$29M at avg $2.57/share; cash position $396M.","Revenue decline primarily from timing of large customer projects in Europe and constrained capital purchase environment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-088578","json":"https://secwatch.observer/filing/0000950170-24-088578.json","markdown":"https://secwatch.observer/filing/0000950170-24-088578.md","text":"https://secwatch.observer/filing/0000950170-24-088578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024088578/0000950170-24-088578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024088578/lab-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:16:21.525653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}